A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy (MOBILE)

Royal College of Surgeons, Ireland

Status: Enrolling

Conditions: Spastic Diplegia; Walking, Difficulty; Cerebral Palsy; Hemiplegic Cerebral Palsy

Treatments: Other: MOBILE

Study type: Interventional

Funder types: Other

Identifiers

NCT06454656

23-163

Details and patient eligibility

About

The goal of this clinical trial is to learn if a new therapy approach to improve walking ability in children with Cerebral Palsy is acceptable to the children and the families in a community setting.

The main questions we look to answer are:

1. Do the children/teens tolerate the therapy and feel that it is helpful?
2. Do the parents/ families feel the therapy helps and is easy to commit to?
3. Do the children/teens complete all their therapy sessions and assessments as planned?

The participants will trial the therapy for 30 hours over 6 weeks and will perform assessments before and after to see if they meet their goals. They will also be interviewed to see how they felt about the therapy when they finish.

Full description

The therapy being trialed in this study uses motor learning theory to try and improve or change walking patterns to improve the child/teen's walking goal.

Therapy will target their own walking goal and they can choose the format of their therapy as long as they complete 30 hours of which 24 hours must be in the clinic within a 6 week period.

Enrollment: 14 estimated patients

Sex: All

Ages: 6 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primary diagnosis of Cerebral Palsy (GMFCS Levels I-III)
• Has a specific walking related goal
• Has capacity to follow instruction
• Has a primary caregiver who can support a home program

Exclusion criteria

• Has had surgery within 6 months of intervention start date
• Has had botox/ baclofen within 3 months of intervention start date
• Has a dual diagnosis that impacts ability to follow instruction
• Has a significant cognitive impairment

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

14 participants in 1 patient group

Intervention

Experimental group

Description:

Participants will undergo 30 hours of therapy over 6 weeks in format of their choosing. A minimum of 24 hours must be completed in clinic with the rest made up of home program.

Treatment:

Other: MOBILE